Company Analysis

Champions Oncology, Inc. (CSBR)

Nasdaq: CSBR · Biological Products, (No Diagnostic Substances) · Baltimore, MD · filing with the SEC since 1995
Grade5.9
◀ Past 6.9● Present 6.6▶ Future 4.1
1 est.

Who runs Champions Oncology, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Ackerman Joel
Chief Executive Officer. First filing Oct 2010, latest Nov 9, 2026, 6 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
10 people on the record since 2007
Officerssales are open-market, Nov 9, 2025 to Nov 9, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ackerman JoelChief Executive OfficerOct 2010Nov 9, 2026none
Sidransky DavidChairman of the BoardJan 2007Nov 9, 2026none
Brainin Robert LawrenceCEOJan 2026Jan 30, 2026none
Directorssales are open-market, Nov 9, 2025 to Nov 9, 2026
NameRoleFirst filingLatest filingSales, 12 months
Mendelson Daniel NewmandirectorMar 2013Nov 9, 2026none
Tobin Scott RdirectorJun 2011Nov 9, 2026none
Breitfeld Philip P.directorNov 2016Nov 7, 2025none
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CSBR · research, not advice